Neuroleptic drugs and the prevention of relapse in schizophrenia: a workshop report.
D000374:Aggression / Q000523:psychology; D000405:Akinetic Mutism / Q000139:chemically induced; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003863:Depression / Q000139:chemically induced; D003937:Diagnosis, Differential; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D012008:Recurrence; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control
D014150:Antipsychotic Agents; D005476:Fluphenazine